Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Novartis India Limited (NSE: NOVARTIND), ISIN INE234A01025 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
NOVARTIND last traded at ₹2026.85 (+2.54%), with a 52-week range of ₹750.00 to ₹2588.00 (as of 23 Sep 2026).
Shareholding as of Jun 2026: promoters 70.68%, FIIs 0.15%, DIIs 1.39%, mutual funds 0.72%.
EquiSense Score (ECS): 64/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.